ROSELAND, NJ-A partnership between Mountain Development Corp. and Square Mile Capital Management LLC has acquired 56 at Roseland, a vacant 433,945-square-foot office building at 56 Livingston Ave., for $18.1 million.

Built in 1982 and once part of the Prudential campus, the facility was later sold to and became the headquarters for pharmaceutical manufacturer Organon, which bought it for $47 million. Organon was acquired by Schering-Plough in November 2007, spending $50 million on renovations. The building was vacated shortly after Merck acquired the company in 2009.

“It’s a tremendous value,” says William Martini, director of acquisitions for Woodland Park, NJ's Mountain Development Corp. “It’s turnkey and ready to go.”

The new owners have retained Jones Lang LaSalle to lease the space, the first time the building has ever been on the general market.

“It’s always been owner-occupied, so not very many people have been inside the building,” says JLL senior vice president Craig Eisenhardt. The space can be subdivided, though JLL is searching for a single user.

The availability dovetails well with the ongoing trend of office tenants fleeing to quality, both Martini and Eisenhardt say, and the unique saw-tooth design of the building allows for dramatic CEO corner offices.

Set on 56 acres, the four-story building features a 15,000-square-foot on-site Tier II+ raised floor data center, a gym and a caf

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM Digital Member, you’ll receive:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.